Are you or any of your collaborators involved in PCSK9-related research and looking for funding to support your work?
ASPIRE CV Competitive Research Grant Program,
an independent competitive grants program supported by Pfizer, is awarding individual grants of up to US $200,000 from a total fund of US $2 million to support projects which bring new insights or advance the understanding of the role of the PCSK9 protein/gene in health and disease.
Letter of Intent (LOI) application deadline: March 13, 2016
Katherine Wilemon on behalf of the ASPIRE Cardiovascular Competitive Research Grant Award Program